You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Catalent acquires Oxfordshire facility to expand biologics in UK and Europe

Catalent has announced the acquisition from the Vaccine Manufacturing and Innovation Centre (VMIC) of a biologics development and manufacturing facility currently under construction near Oxford, UK.